FIELD: medicine, pharmaceutics.
SUBSTANCE: invention concerns compositions with combinations of anesthetics, anti-inflammatory, immune modulation and cartilage reconstruction agents, particularly including saligenin, boswellic acid, procyanidins, N-acetyl-glucosamine, and glucuronic acid or glucuronolactone, applied in rheumatoid arthritis treatment and arthritis states in general.
EFFECT: reduced pain and muscular regidity, improved physiological function after 14 day treatment.
2 ex
